LGNDZ Financials
Ligand Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$0.00
Market Cap
-
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$268.09M
Gross Profit
$220.83M
Operating Income
$47.20M
Net Income
$124.45M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$1.56B
Total Liabilities
$543.42M
Shareholders Equity
$1.02B
Cash & Equivalents
$174.93M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$49.36M
CapEx
$452000
Free Cash Flow
$48.91M
Profitability Metrics
Gross Margin
64.3%
Operating Margin
0.3%
Net Margin
0.5%
ROE
0.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is LGNDZ revenue?
LGNDZ's most recent quarterly revenue was $268.09M. Annual revenue can be calculated by summing the four most recent quarters.
Is LGNDZ profitable?
LGNDZ reported a profit of $124.45M in the most recent quarter. The net profit margin is 0.5%.
What is LGNDZ market cap?
Market cap data for LGNDZ is available above.
Does LGNDZ have debt?
View LGNDZ's balance sheet for debt information.
What is LGNDZ cash flow?
LGNDZ's most recent quarterly free cash flow was $48.91M.